American Research & Management Company’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $257K | Sell |
3,657
-270
| -7% | -$21.2K | 0.07% | 112 |
|
|
2022
Q2 | $315K | Sell |
3,927
-317
| -7% | -$24.8K | 0.08% | 103 |
|
|
2022
Q1 | $322K | Sell |
4,244
-217
| -5% | -$17.2K | 0.07% | 113 |
|
|
2021
Q4 | $381K | Hold |
4,461
| – | – | 0.08% | 106 |
|
|
2021
Q3 | $337K | Sell |
4,461
-100
| -2% | -$7.94K | 0.08% | 107 |
|
|
2021
Q2 | $371K | Hold |
4,561
| – | – | 0.08% | 104 |
|
|
2021
Q1 | $360K | Sell |
4,561
-110
| -2% | -$8.62K | 0.09% | 110 |
|
|
2020
Q4 | $399K | Buy |
4,671
+1,710
| +58% | +$141K | 0.1% | 105 |
|
|
2020
Q3 | $228K | Hold |
2,961
| – | – | 0.07% | 114 |
|
|
2020
Q2 | $217K | Hold |
2,961
| – | – | 0.07% | 115 |
|
|
2020
Q1 | $196K | Hold |
2,961
| – | – | 0.07% | 113 |
|
|
2019
Q4 | $204K | Sell |
2,961
-2,200
| -43% | -$150K | 0.06% | 126 |
|
|
2019
Q3 | $379K | Buy |
5,161
+200
| +4% | +$14.5K | 0.11% | 108 |
|
|
2019
Q2 | $356K | Hold |
4,961
| – | – | 0.11% | 112 |
|
|
2019
Q1 | $340K | Buy |
4,961
+4,451
| +873% | +$288K | 0.1% | 115 |
|
|
2018
Q4 | $30K | Hold |
510
| – | – | 0.01% | 201 |
|
|
2018
Q3 | $34K | Hold |
510
| – | – | 0.01% | 209 |
|
|
2018
Q2 | $33K | Sell |
510
-50
| -9% | -$3.27K | 0.01% | 199 |
|
|
2018
Q1 | $40K | Hold |
560
| – | – | 0.01% | 197 |
|
|
2017
Q4 | $42K | Hold |
560
| – | – | 0.01% | 214 |
|
|
2017
Q3 | $41K | Hold |
560
| – | – | 0.01% | 200 |
|
|
2017
Q2 | $42K | Hold |
560
| – | – | 0.01% | 184 |
|
|
2017
Q1 | $41K | Sell |
560
-50
| -8% | -$3.5K | 0.01% | 177 |
|
|
2016
Q4 | $40K | Hold |
610
| – | – | 0.01% | 188 |
|
|
2016
Q3 | $45K | Hold |
610
| – | – | 0.02% | 182 |
|
|
2016
Q2 | $45K | Sell |
610
-50
| -8% | -$3.56K | 0.02% | 169 |
|
|
2016
Q1 | $47K | Sell |
660
-100
| -13% | -$6.65K | 0.02% | 165 |
|
|
2015
Q4 | $51K | Buy |
760
+80
| +12% | +$5.32K | 0.02% | 164 |
|
|
2015
Q3 | $43K | Hold |
680
| – | – | 0.02% | 171 |
|
|
2015
Q2 | $44K | Hold |
680
| – | – | 0.02% | 185 |
|
|
2015
Q1 | $47K | Sell |
680
-400
| -37% | -$27.6K | 0.02% | 180 |
|
|
2014
Q4 | $75K | Hold |
1,080
| – | – | 0.03% | 149 |
|
|
2014
Q3 | $70K | Hold |
1,080
| – | – | 0.03% | 153 |
|
|
2014
Q2 | $74K | Hold |
1,080
| – | – | 0.03% | 152 |
|
|
2014
Q1 | $70K | Buy |
1,080
+190
| +21% | +$12K | 0.02% | 154 |
|
|
2013
Q4 | $58K | Hold |
890
| – | – | 0.02% | 167 |
|
|
2013
Q3 | $53K | Buy |
890
+200
| +29% | +$11.8K | 0.02% | 165 |
|
|
2013
Q2 | $40K | Buy |
+690
| New | +$41K | 0.02% | 181 |
|
Other funds holding CL
TP
American Research & Management Company's CL Position: Q3 2022 in Review
American Research & Management Company reduced its Colgate-Palmolive (CL) stake by 6.9% in Q3 2022, selling an estimated $21.2K and leaving 3,657 shares worth $257K. The position accounts for 0.07% of the portfolio, ranked #112.
American Research & Management Company first reported a position in CL in Q2 2013 and has held it in 38 quarters since. The position peaked at $399K in Q4 2020. 1,615 funds tracked by Wall St. Rank hold CL as of Q3 2022.
- American Research & Management Company held 3,657 shares of Colgate-Palmolive worth $257K as of Q3 2022.
- American Research & Management Company sold 270 Colgate-Palmolive shares in Q3 2022, an estimated $21.2K.
- Colgate-Palmolive made up 0.07% of American Research & Management Company's portfolio in Q3 2022, its #112 holding.
- American Research & Management Company first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 38 quarters since.
- American Research & Management Company's Colgate-Palmolive position peaked at $399K in Q4 2020.
- 1,615 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.
Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.